Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will participate in a fireside chat at the virtual Goldman Sachs Annual Global Healthcare Conference on Thursday, June 11, 2020 at 10:30 a.m. EDT.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, June 3, 2020
Information
Tags: 
FDA, Health, Other Health, Clinical trials, Pharmaceutical, Biotechnology, Articles, Life sciences, Psychiatry, Abnormal psychology, Mental disorder, Psychiatric assessment, Psychiatric diagnosis, Psychopathology, Biopharmaceutical
Geotags: 
United States, Massachusetts
⚠ generated by AI ↴
Summary
Key Points: 
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will participate in a fireside chat at the virtual Goldman Sachs Annual Global Healthcare Conference on Thursday, June 11, 2020 at 10:30 a.m. EDT.
  • A live webcast of the fireside chat will be available on the Investor Relations page of Karunas website at investors.karunatx.com .
  • A replay of the webcast will also be archived for up to 90 days on Karunas website following the conference.
  • Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders which remain among the most disabling and potentially fatal disorders worldwide.


Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will participate in a fireside chat at the virtual Goldman Sachs Annual Global Healthcare Conference on Thursday, June 11, 2020 at 10:30 a.m. EDT.

A live webcast of the fireside chat will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 90 days on Karuna’s website following the conference.

About Karuna

Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric and pain management patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.

Copyright: 
Copyright Business Wire 2020